Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperprogression”

2 trials

Showing 2 of 2 results

Not applicableLooking for participantsNCT06276088
What this trial is testing

Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy

Who this might be right for
ImmunotherapyHyperprogressionBiomarker
Nanfang Hospital, Southern Medical University 374
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07274384
What this trial is testing

Hyperprogression in PD-L1 ≥ 50% NSCLC: a Biomarker Guided Phase 2 Trial

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Hyperprogression
Università Vita-Salute San Raffaele 74

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation